Jan K. Rudzinski

The University of Texas MD Anderson Cancer Center

Papers

3

Total Citations

16

H-Index

2

About

Dr. Jan K. Rudzinski is a pioneering urologic surgeon whose work centers on robotic-assisted oncologic surgery, with a particular focus on prostate and penile cancers. His landmark 2023 study, cited 8 times, provided critical long-term data on 15-year biochemical failure, metastasis, and survival rates following robotic radical prostatectomy for PSA-detected prostate cancer—offering invaluable benchmarks for treatment decision-making. Dr. Rudzinski has also revolutionized the management of penile cancer through his expertise in robotic inguinal lymph node dissection. His 2024 work, with 7 citations, demonstrated that this minimally invasive approach is a safe and effective staging procedure for high-risk, clinically node-negative patients, challenging traditional open surgery. His 2025 technical guide, detailing tips and tricks for the procedure, further underscores his role as a leading educator in the field. By showing that robotic techniques can reduce the historically high morbidity of inguinal lymph node dissection while maintaining diagnostic and therapeutic efficacy, Dr. Rudzinski has advanced both surgical precision and patient quality of life. His contributions are shaping modern, less invasive standards of care in urologic oncology.

Research Focus

Key Achievements

2
H-Index
3
Papers
16
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
15-year biochemical failure, metastasis, salvage therapy, and cancer-specific and overall survival rates in men treated with robotic radical prostatectomy for PSA-screen detected prostate cancer
8 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 32
🏛 Institutions: The University of Texas MD Anderson Cancer Center

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago